| | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
---|
What is an ATC-Code? | ATC-Overview |
|
| | IP | CI | | Hirudoid | 40 g | 4.24 | 7.85 | 10 % | | Cream: Heparinoidum (Chondroitini Polysulfas) 3 mg | Medinova AG | D / SL | FB | | G |  |
| | IP | CI | | Hirudoid | 100 g | 8.50 | 15.70 | 10 % | | Cream: Heparinoidum (Chondroitini Polysulfas) 3 mg | Medinova AG | D / SL | FB | | G |  |
| | IP | CI | | Hirudoid | 40 g | 4.24 | 7.85 | 10 % | | Gel: Heparinoidum (Chondroitini Polysulfas) 3 mg | Medinova AG | D / SL | FB | | G |  |
| | IP | CI | | Hirudoid | 100 g | 8.50 | 15.70 | 10 % | | Gel: Heparinoidum (Chondroitini Polysulfas) 3 mg | Medinova AG | D / SL | FB | | G |  |
| | IP | CI | | Hirudoid forte | 40 g | PR | PR | k.A. | | Cream: Heparinoidum (Chondroitini Polysulfas) 4.45 mg | Medinova AG | D | FB | | G |  |
| | IP | CI | | Hirudoid forte | 100 g | PR | PR | k.A. | | Cream: Heparinoidum (Chondroitini Polysulfas) 4.45 mg | Medinova AG | D | FB | | G |  |
| | IP | CI | CM | Varidoid | 40 g | PR | PR | k.A. | | Cream: Heparinoidum (Chondroitini Polysulfas) 3 mg | Bridging Pharma GmbH | D | FB | | G |  |
| | IP | CI | CM | Varidoid | 100 g | PR | PR | k.A. | | Cream: Heparinoidum (Chondroitini Polysulfas) 3 mg | Bridging Pharma GmbH | D | FB | | G |  |
| | IP | CI | | Hirudoid forte | 40 g | PR | PR | k.A. | | Gel: Heparinoidum (Chondroitini Polysulfas) 4.45 mg | Medinova AG | D | FB | | G |  |
| | IP | CI | | Hirudoid forte | 100 g | PR | PR | k.A. | | Gel: Heparinoidum (Chondroitini Polysulfas) 4.45 mg | Medinova AG | D | FB | | G |  |
| | IP | CI | CM | Varidoid | 40 g | PR | PR | k.A. | | Gel: Heparinoidum (Chondroitini Polysulfas) 3 mg | Bridging Pharma GmbH | D | FB | | G |  |
| | IP | CI | CM | Varidoid | 100 g | PR | PR | k.A. | | Gel: Heparinoidum (Chondroitini Polysulfas) 3 mg | Bridging Pharma GmbH | D | FB | | G |  |
| | | CI | | Hemeran | 120 ml | PR | 21.15 | k.A. | | Lotion: 2 Active Agents | NOVARTIS CONSUMER HEALTH SCHWEIZ AG | D | FB | | G |  |
|
| | IP | CI | | HepaGel | 50 g | 5.50 | 10.15 | 10 % | | Gel: Heparinum Natricum 400 UI | Spirig HealthCare AG | D / SL | FB | | G |  |
| | IP | CI | | HepaGel | 100 g | 9.77 | 18.05 | 10 % | | Gel: Heparinum Natricum 400 UI | Spirig HealthCare AG | D / SL | FB | | G |  |
| | IP | CI | | Lioton 1000 | 50 g | 6.57 | 12.15 | 10 % | | Gel: Heparinum Natricum 1000 UI | A. Menarini GmbH | D / SL | FB | | G |  |
| | IP | CI | | Lioton 1000 | 100 g | 12.13 | 22.40 | 10 % | | Gel: Heparinum Natricum 1000 UI | A. Menarini GmbH | D / SL | FB | | G |  |
| | IP | CI | | Lyman 40'000 Mono | 100 ml | 10.20 | 18.85 | 10 % | | Spray: Heparinum Natricum 400 UI/ml | Drossapharm AG | D / SL | FB | | G |  |
| | IP | CI | CM | Demovarin forte | 100 g | PR | 22.50 | k.A. | | hydrogel: Heparinum Natricum 400 UI | VERFORA SA | D | FB | | G |  |
|
| | IP | CI | Ph | Alpinamed Ruscovarin Venen Gel | 100 g | PR | PR | k.A. | | 2 Active Agents | Alpinamed AG | D | FB | | G |  |
| | IP | CI | Ph | Alpinamed Ruscovarin Venen Gel | 200 g | PR | PR | k.A. | | 2 Active Agents | Alpinamed AG | D | FB | | G |  |
| | IP | CI | PhCM | Swidro Rusco Salben-Gel | 100 g | PR | PR | k.A. | | Gel: 2 Active Agents | Alpinamed AG | D | FB | | G |  |
| | IP | CI | PhCM | Swidro Rusco Salben-Gel | 200 g | PR | PR | k.A. | | Gel: 2 Active Agents | Alpinamed AG | D | FB | | G |  |
| | IP | CI | | Keli-med | 20 g | 7.38 | 13.65 | 10 % | | Cream: 6 Active Agents | Permamed AG | D / SL | FB | | G |  |
| | IP | CI | | Keli-med | 50 g | 15.27 | 28.20 | 10 % | | Cream: 6 Active Agents | Permamed AG | D / SL | FB | | G |  |
| | IP | CI | | Contractubex | 20 g | 7.31 | 13.50 | 10 % | | Gel: 3 Active Agents | Merz Pharma (Schweiz) AG | D / SL | FB | | G |  |
| | IP | CI | | Contractubex | 50 g | 15.74 | 29.05 | 10 % | | Gel: 3 Active Agents | Merz Pharma (Schweiz) AG | D / SL | FB | | G |  |
| | IP | CI | | Dolobene | 50 g | 4.03 | 7.45 | 10 % | | Gel: 3 Active Agents | Mepha Pharma AG | D / SL | FB | | G |  |
| | IP | CI | | Lyman-50'000 | 40 g | 6.33 | 11.70 | 10 % | | Gel: 3 Active Agents | Drossapharm AG | D / SL | FB | | G |  |
| | IP | CI | | Lyman-50'000 | 100 g | 13.31 | 24.60 | 10 % | | Gel: 3 Active Agents | Drossapharm AG | D / SL | FB | | G |  |
| | IP | CI | | Gorgonium | 30 g | 11.15 | 20.60 | 10 % | | Ointment: 3 Active Agents | Drossapharm AG | D / SL | FB | | G |  |
| | IP | CI | | Lyman-50'000 | 40 g | 6.33 | 11.70 | 10 % | | Ointment: 3 Active Agents | Drossapharm AG | D / SL | FB | | G |  |
| | IP | CI | | Lyman-50'000 | 100 g | 13.31 | 24.60 | 10 % | | Ointment: 3 Active Agents | Drossapharm AG | D / SL | FB | | G |  |
| | IP | CI | | Lyman 50'000 | 40 g | 6.33 | 11.70 | 10 % | | Emgel: 3 Active Agents | Drossapharm AG | D / SL | FB | | G |  |
| | IP | CI | | Lyman 50'000 | 100 g | 13.31 | 24.60 | 10 % | | Emgel: 3 Active Agents | Drossapharm AG | D / SL | FB | | G |  |
| | IP | CI | | Contractubex | 100 g | PR | 62.65 | k.A. | | Gel: 3 Active Agents | Merz Pharma (Schweiz) AG | D | FB | | G |  |
| | IP | CI | | Lyman-200'000 forte | 40 g | PR | PR | k.A. | | Gel: 4 Active Agents | Drossapharm AG | D | FB | | G |  |
| | IP | CI | | Lyman-200'000 forte | 100 g | PR | PR | k.A. | | Gel: 4 Active Agents | Drossapharm AG | D | FB | | G |  |
| | IP | CI | | Gorgonium | 60 g | PR | PR | k.A. | | Ointment: 3 Active Agents | Drossapharm AG | D | FB | | G |  |
| | IP | CI | | Lyman-200'000 forte | 40 g | PR | PR | k.A. | | Ointment: 3 Active Agents | Drossapharm AG | D | FB | | G |  |
| | IP | CI | | Lyman-200'000 forte | 100 g | PR | PR | k.A. | | Ointment: 3 Active Agents | Drossapharm AG | D | FB | | G |  |
| | IP | CI | | Lyman 200'000 forte | 60 g | PR | PR | k.A. | | Emgel: 3 Active Agents | Drossapharm AG | D | FB | | G |  |
| | IP | CI | | Lyman 200'000 forte | 100 g | PR | PR | k.A. | | Emgel: 3 Active Agents | Drossapharm AG | D | FB | | G |  |
| | IP | CI | | Hepabuzon | 30 g | PR | 7.45 | 10 % | | Cream: 2 Active Agents | Spirig Pharma AG | C / SL | FB | | G |  |
| | IP | CI | | Hepabuzon | 100 g | PR | 18.80 | 10 % | | Cream: 2 Active Agents | Spirig Pharma AG | C / SL | FB | | G |  |
| | | CI | | Hepathrombin 50 000 | 60 g | PR | 15.15 | k.A. | | Ointment: 3 Active Agents | Lyron AG | D | FB | | G |  |
|
| | IP | | | Aethoxysklerol 0.5 % | 5 x 2 ml | PR | 18.50 | k.A. | | | Recordati AG | B | FB | | G |  |
| | IP | | | Aethoxysklerol 1 % | 5 x 2 ml | PR | PR | k.A. | | | Recordati AG | B | FB | | G |  |
| | IP | | | Aethoxysklerol 2 % | 5 x 2 ml | PR | PR | k.A. | | | Recordati AG | B | FB | | G |  |
| | IP | | | Aethoxysklerol 3 % | 5 x 2 ml | PR | PR | k.A. | | | Recordati AG | B | FB | | G |  |
| | IP | | | Aethoxysklerol 0.25 % | 5 x 2 ml | PR | 16.50 | k.A. | | | Recordati AG | B | FB | | G |  |
| | IP | | | Sclerovein 0,5 % | 30 ml | PR | PR | k.A. | | | Resinag AG | B | FB | | G |  |
| | IP | | | Sclerovein 1 % | 30 ml | PR | PR | k.A. | | | Resinag AG | B | FB | | G |  |
| | IP | | | Sclerovein 2 % | 30 ml | PR | PR | k.A. | | | Resinag AG | B | FB | | G |  |
| | IP | | | Sclerovein 3 % | 30 ml | PR | PR | k.A. | | | Resinag AG | B | FB | | G |  |
| | IP | | | Sclerovein 5 % | 30 ml | PR | PR | k.A. | | | Resinag AG | B | FB | | G |  |
|
| | IP | CI | | Doxium 500 | 30 Capsule(s) | 7.90 | 17.85 | 10 % | | Capsules: Calcii Dobesilas Monohydricus 500 mg | OM Pharma SA | B / SL | FB | | G |  |
| | IP | CI | | Doxium 500 | 60 Capsule(s) | 13.91 | 31.55 | 10 % | | Capsules: Calcii Dobesilas Monohydricus 500 mg | OM Pharma SA | B / SL | FB | | G |  |
| | IP | | CM | Doxocur 500 mg | 30 | 7.90 | 17.85 | 10 % | | Capsules: Calcii Dobesilas Monohydricus 500 mg | OM Pharma Suisse SA | B / SL | FB | | G |  |
| | IP | | CM | Doxocur 500 mg | 60 | 13.91 | 31.55 | 10 % | | Capsules: Calcii Dobesilas Monohydricus 500 mg | OM Pharma Suisse SA | B / SL | FB | | G |  |